On behalf of Bioscience Unit, our only comment relates to the Technology Strategy, since this will be the main way in which DTI funding for science will materialise in future outside of Research Council funding. We note that Section 5.2 mentions the strategy and that it appears that control of science seems to be moving to a more centralised approach. Important to note that the Technology Strategy Board which will be steering decisions is industry-led and the focus is therefore likely to be on industry priorities ie wealth creation/competitiveness.

We think others are more fitted to provide detailed comments.


NATALIA DAVIE
Bioscience Unit (BR1)